An open comparison of clozapine and risperidone in treatment-resistant schizophrenia

Pharmacopsychiatry
S W FlynnW G Honer

Abstract

Clozapine and risperidone are used in treatment-resistant schizophrenia. At present, there are few reported comparisons of these drugs in this population. We report on a consecutive series of treatment-resistant schizophrenics given either clozapine or risperidone in open clinical trials. Subjects were treated with clozapine (n = 57) or risperidone (n = 29). Pretreatment GAF, CGI, and PANSS scores did not differ between the groups, nor did demographic variables including age, age at first hospitalization, years ill, number of previous hospitalizations, or gender. The mean treatment trial was 12.1 weeks, with mean doses of clozapine 420 mg, and risperidone 7.75 mg. The length of the trial did not differ significantly between the groups. Response was taken to be a 20% decrease in the PANSS score. Using repeated measures ANOVA, PANSS total scores (F = 5.3, p = 0.02) and positive subscore (F = 7.4, p = 0.008) showed greater improvement in the clozapine group than the risperidone group, while other PANSS subscores showed a trend toward greater improvement with clozapine. The PANSS-derived factors of excitement (F = 6.7, p = 0.01), psychosocial withdrawal (F = 3.8, p = 0.05), and psychomotor retardation (F = 3.9, p = 0.05) improved m...Continue Reading

Citations

Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Claire AdvokatJoseph E Comaty
Apr 6, 2004·Schizophrenia Research·Peter F BuckleyRobin A Emsley
Dec 1, 1999·Biological Psychiatry·J M Kane
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Wai-Kwong Tang, Gabor S Ungvari
Jul 6, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·S Frangou, M Lewis
Jan 6, 2010·Indian Journal of Psychiatry·R K SolankiDeepti Munshi
Jan 5, 2001·European Child & Adolescent Psychiatry·H RemschmidtE Schulz
Oct 22, 2002·Expert Opinion on Investigational Drugs·Gina KuperbergRobin Murray
May 4, 2004·Current Medical Research and Opinion·Stephen Layton, Martin Barbeau
Sep 22, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Peter FalkaiUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Dec 3, 2005·Child and Adolescent Psychiatric Clinics of North America·Harvey N KranzlerSanjiv Kumra
Dec 18, 2001·Biological Psychiatry·R R Conley, D L Kelly
May 1, 2003·Expert Review of Neurotherapeutics·Jambur AnanthSarath Gunatilake
Oct 18, 2011·Schizophrenia Research·Takefumi SuzukiDavid C Mamo
Sep 22, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Alexandra L SpornNitin Gogtay
Feb 24, 2001·Journal of Psychopharmacology·D M Taylor, D Duncan-McConnell
May 5, 2000·The Cochrane Database of Systematic Reviews·A TuunainenS M Gilbody
Apr 4, 2000·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·H RemschmidtE Schulz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here